IRIS Accounts Production v23.2.0.158 06800311 Board of Directors 1.4.22 31.3.23 31.3.23 true false true false false true false Ordinary 1.00000 47177 47177 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh068003112022-03-31068003112023-03-31068003112022-04-012023-03-31068003112021-03-31068003112021-04-012022-03-31068003112022-03-3106800311ns10:Originalns15:EnglandWales2022-04-012023-03-3106800311ns14:PoundSterlingns10:Original2022-04-012023-03-3106800311ns10:Originalns10:Director12022-04-012023-03-3106800311ns10:Original2022-04-012023-03-3106800311ns10:Original2023-03-3106800311ns10:Originalns10:PrivateLimitedCompanyLtd2022-04-012023-03-3106800311ns10:Originalns10:SmallEntities2022-04-012023-03-3106800311ns10:Originalns10:AuditExempt-NoAccountantsReport2022-04-012023-03-3106800311ns10:Originalns10:SmallCompaniesRegimeForDirectorsReport2022-04-012023-03-3106800311ns10:SmallCompaniesRegimeForAccountsns10:Original2022-04-012023-03-3106800311ns10:Originalns10:FullAccounts2022-04-012023-03-3106800311ns10:Originalns10:OrdinaryShareClass12022-04-012023-03-3106800311ns10:Original41ns10:Director12022-04-012023-03-3106800311ns10:Original41ns10:Director12023-03-3106800311ns10:Originalns10:Director22022-04-012023-03-3106800311ns10:Originalns10:Director32022-04-012023-03-3106800311ns10:CompanySecretary1ns10:Original2022-04-012023-03-3106800311ns10:Originalns10:RegisteredOffice2022-04-012023-03-3106800311ns10:Original2022-03-3106800311ns10:Originalns5:CurrentFinancialInstruments2023-03-3106800311ns10:Originalns5:CurrentFinancialInstruments2022-03-3106800311ns10:Originalns5:Non-currentFinancialInstruments2023-03-3106800311ns10:Originalns5:Non-currentFinancialInstruments2022-03-3106800311ns5:ShareCapitalns10:Original2023-03-3106800311ns5:ShareCapitalns10:Original2022-03-3106800311ns10:Originalns5:RetainedEarningsAccumulatedLosses2023-03-3106800311ns10:Originalns5:RetainedEarningsAccumulatedLosses2022-03-3106800311ns10:Original2021-04-012022-03-3106800311ns10:Originalns5:CostValuation2022-03-3106800311ns10:Originalns5:Subsidiary12022-04-012023-03-3106800311ns10:Originalns5:Subsidiary112022-04-012023-03-3106800311ns10:Originalns5:Subsidiary12023-03-3106800311ns10:Originalns5:Subsidiary12022-03-3106800311ns10:Originalns5:Subsidiary12021-04-012022-03-3106800311ns10:Originalns10:OrdinaryShareClass12023-03-3106800311ns10:Originalns10:Director222022-03-3106800311ns10:Originalns10:Director222021-03-3106800311ns10:Originalns10:Director222022-04-012023-03-3106800311ns10:Originalns10:Director222021-04-012022-03-3106800311ns10:Originalns10:Director222023-03-3106800311ns10:Originalns10:Director222022-03-3106800311ns10:Originalns10:Director332022-03-3106800311ns10:Originalns10:Director332021-03-3106800311ns10:Originalns10:Director332022-04-012023-03-3106800311ns10:Originalns10:Director332021-04-012022-03-3106800311ns10:Originalns10:Director332023-03-3106800311ns10:Originalns10:Director332022-03-31
REGISTERED NUMBER: 06800311 (England and Wales)














Unaudited Financial Statements

for the Year Ended 31 March 2023

for

MAPLE HEALTHCARE LIMITED

MAPLE HEALTHCARE LIMITED (REGISTERED NUMBER: 06800311)

Contents of the Financial Statements
for the year ended 31 March 2023










Page

Company Information 1

Statement of Financial Position 2

Notes to the Financial Statements 3


MAPLE HEALTHCARE LIMITED

Company Information
for the year ended 31 March 2023







Directors: Mr K P Sohal
Mrs H K Sohal
Mr K I S Sohal





Secretary: Mr K P Sohal





Registered office: The Bungalow
47 Colchester Road
White Colne
Colchester
Essex
CO6 2PW





Registered number: 06800311 (England and Wales)





Accountants: Haines Watts Essex LLP
Chartered Accountants
Juniper House
Warley Hill Business Park
The Drive
Brentwood
Essex
CM13 3BE

MAPLE HEALTHCARE LIMITED (REGISTERED NUMBER: 06800311)

Statement of Financial Position
31 March 2023

2023 2022
Notes £    £    £    £   
Fixed assets
Investments 4 1,574,663 1,574,663

Creditors
Amounts falling due within one year 5 88,626 1,350
Net current liabilities (88,626 ) (1,350 )
Total assets less current liabilities 1,486,037 1,573,313

Creditors
Amounts falling due after more than one
year

6

1,202,157

1,337,933
Net assets 283,880 235,380

Capital and reserves
Called up share capital 7 1,000 1,000
Retained earnings 282,880 234,380
Shareholders' funds 283,880 235,380

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 12 October 2023 and were signed on its behalf by:





Mr K P Sohal - Director


MAPLE HEALTHCARE LIMITED (REGISTERED NUMBER: 06800311)

Notes to the Financial Statements
for the year ended 31 March 2023


1. Statutory information

Maple Healthcare Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. Accounting policies

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Investments in subsidiaries
Investments in subsidiary undertakings are recognised at cost.

Financial instruments
Financial assets and financial liabilities are recognised in the balance sheet when the company becomes a party to the contractual provisions of the instrument.

Trade and other debtors and creditors are classified as basic financial instruments and measured at initial recognition at transaction price. Debtors and creditors are subsequently measured at amortised cost using the effective interest rate method. A provision is established when there is objective evidence that the company will not be able to collect all amounts due.

Cash and cash equivalents are classified as basic financial instruments and comprise cash in hand and at bank and bank overdrafts.

Financial liabilities and equity instruments issued by the company are classified in accordance with the substance of the contractual arrangements entered into and the definitions of a financial liability and an equity instrument. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities. Equity instruments issued by the company are recorded at the proceeds received, net of direct issue costs.

Preparation of consolidated financial statements
The financial statements contain information about Maple Healthcare Ltd as an individual company and do not contain consolidated financial information as the parent of a group. The company has taken the option under section 398 of the Companies Act 2006 not to prepare consolidated financial statements.

3. Employees and directors

The average number of employees during the year was 3 (2022 - 3 ) .

4. Fixed asset investments
Shares in
group
undertakings
£   
Cost
At 1 April 2022
and 31 March 2023 1,574,663
Net book value
At 31 March 2023 1,574,663
At 31 March 2022 1,574,663

MAPLE HEALTHCARE LIMITED (REGISTERED NUMBER: 06800311)

Notes to the Financial Statements - continued
for the year ended 31 March 2023


4. Fixed asset investments - continued

The company's investments at the Statement of Financial Position date in the share capital of companies include the following:

Comfort Care Services (Colchester) Ltd
Registered office:
Nature of business: Residential care home
%
Class of shares: holding
Ordinary 100.00
2023 2022
£    £   
Aggregate capital and reserves 1,135,824 1,111,267
Profit for the year 74,557 103,981

5. Creditors: amounts falling due within one year
2023 2022
£    £   
Trade creditors 1,500 -
Other creditors 87,126 1,350
88,626 1,350

6. Creditors: amounts falling due after more than one year
2023 2022
£    £   
Other creditors 1,202,157 1,337,933

7. Called up share capital

Allotted, issued and fully paid:
Number: Class: Nominal 2023 2022
value: £    £   
1,000 Ordinary £1 1,000 1,000

8. Directors' advances, credits and guarantees

The following advances and credits to directors subsisted during the years ended 31 March 2023 and 31 March 2022:

2023 2022
£    £   
Mrs H K Sohal and Mr K P Sohal
Balance outstanding at start of year - -
Amounts repaid (47,177 ) -
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year (47,177 ) -

MAPLE HEALTHCARE LIMITED (REGISTERED NUMBER: 06800311)

Notes to the Financial Statements - continued
for the year ended 31 March 2023


8. Directors' advances, credits and guarantees - continued

Mr K I S Sohal
Balance outstanding at start of year - -
Amounts repaid (38,599 ) -
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year (38,599 ) -

9. Related party disclosures

The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group.

JK Healthcare Ltd

A company under common control.


2023 2022
£    £   
Amount due to related party at the balance sheet date - 85,776

The loan is interest free and is repayable in 53 weeks.

Sohal Healthcare Ltd

A company under common control.


2023 2022
£    £   
Amount due to related party at the balance sheet date 162,013 162,013

The loan is interest free and is repayable in 53 weeks.

Milton Lodge Limited

A company under common control.


2023 2022
£    £   
Amount due to related party at the balance sheet date 58,955 58,955

The loan is interest free and is repayable in 53 weeks.

MAPLE HEALTHCARE LIMITED (REGISTERED NUMBER: 06800311)

Notes to the Financial Statements - continued
for the year ended 31 March 2023


9. Related party disclosures - continued

Brook House Health Ltd

A company under common control.


2023 2022
£    £   
Amount due to related party at the balance sheet date 72,877 72,877

The loan is interest free and is repayable in 53 weeks.

Hardwick Dene Limited

A company under common control.


2023 2022
£    £   
Amount due to related party at the balance sheet date 41,743 41,743

The loan is interest free and is repayable in 53 weeks.

The Willows Ipswich Limited

A company under common control.


2023 2022
£    £   
Amount due to related party at the balance sheet date 5,390 5,390

The loan is interest free and is repayable in 53 weeks.

Comfort Care Services (Colchester) Ltd

A company under common control.


2023 2022
£    £   
Amount due to related party at the balance sheet date 856,900 906,900

The loan is interest free and is repayable in 53 weeks.

Hazeldell Limited

A company under common control.


2023 2022
£    £   
Amount due to related party at the balance sheet date 4,278 4,278

The loan is interest free and is repayable in 53 weeks.